Product Search

As a leading provider of generic drugs, Teva is pleased to offer a diverse portfolio of FDA-approved generic products. Approximately 500 Teva medicines are currently available, covering all major therapeutic categories.

View a list of our innovative medicines View a list of our biosimilars

Download/Print

Download a PDF of Teva’s Generic Product Catalog to save or print.

Download Catalog PDF

Filters

Therapeutic Category

Toggle

Product Form

Toggle

All Results

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

Clear Filters

Dexmethylphenidate Hydrochloride Extended-Release Capsules CII

Brand Equivalent:
Focalin XR® Extended-Release Capsules [CII]

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed-Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules CII

Brand Equivalent:
Mydayis® Extended-Release Capsules CII

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules CII

Brand Equivalent:
Adderall XR® Capsules [CII]

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets CII

Brand Equivalent:
Adderall® Tablets [CII]

Dextroamphetamine Sulfate Extended-Release Capsules CII

Brand Equivalent:
Dexedrine® Spansule® [CII]

Dextroamphetamine Sulfate Tablets, USP CII

Brand Equivalent:
Dextrostat® Tablets [CII]

Methylphenidate Hydrochloride Extended-Release Capsules (CD) CII

Brand Equivalent:
Metadate CD® Extended-Release Capsules [CII]

Methylphenidate Hydrochloride Extended-Release Tablets, USP CII

Brand Equivalent:
Concerta® Extended-Release Tablets [CII]